Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Keratosis, Actinic × Diclofenac × Clear all

Phase

Phase 4 6 Phase 3 4 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 1 Keratosis, Actinic 1

Interventions

3-ingenyl angelate 7 Radiotherapy 3 Prilocaine 3 Lidocaine 3 Imiquimod 2 Gels 2 BF-200 ALA 2 Aminolevulinic Acid 2 calcipotriene 1 beta-solamarine 1 Vitamin D 1 Solutions 1 Powders 1 Niacinamide 1 LEO 43204 1 Imipramine 1 Fluorouracil 1 Diclofenac 1 Celecoxib 1 Aluminum Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01742663 2014-01-22

A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis

Sun Pharmaceutical Industries, Inc.

Phase 1 Completed

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡